The Genomics in Cancer Care Market is gaining importance as healthcare providers increasingly use genetic information to improve cancer diagnosis and treatment decisions. The market was valued at USD 30.57 billion in 2023 and is expected to grow from USD 31.83 billion in 2024 to USD 44.0 billion by 2032, registering a CAGR of 4.13% during the forecast period of 2025–2032. Growing cancer prevalence, advancements in genomic sequencing, and rising demand for personalized medicine are supporting market development. Genomic technologies help healthcare professionals identify genetic changes associated with cancer, understand disease progression, and select more targeted treatment approaches.

Technological innovations such as next-generation sequencing, polymerase chain reaction (PCR), microarray technology, and CRISPR are creating new opportunities in cancer research and clinical applications. Increasing investments in biotechnology, growing awareness of genomic testing, and improvements in early cancer detection are further contributing to industry expansion. The market also offers opportunities through liquid biopsy technologies and the integration of artificial intelligence into genomic data analysis. Major companies operating in this sector include GRAIL, Roche, Illumina, Qiagen, and Guardant Health. As precision medicine continues to advance, genomics is expected to play an increasingly important role in improving cancer care and supporting innovative treatment strategies.

Q1. What is the Genomics in Cancer Care Market?

The market focuses on genomic technologies and services used for cancer diagnosis, treatment selection, prognosis, and research.

Q2. What is the projected market size by 2032?

The market is expected to reach USD 44.0 billion by 2032.

Q3. What is the expected CAGR of the market?

The market is projected to grow at a CAGR of 4.13% during 2025–2032.

Q4. Which technologies are used in genomics for cancer care?

Key technologies include next-generation sequencing, polymerase chain reaction, microarrays, and CRISPR.

Q5. Who are the major companies in the Genomics in Cancer Care Market?

Major companies include GRAIL, Roche, Illumina, Qiagen, Guardant Health, and Thermo Fisher Scientific.